Saponia kemijska, prehrambena i farmaceutska industrija d.d. financials
Saponia kemijska, prehrambena i farmaceutska industrija d.d.
Country: HR Reporting currency: HRK Latest annual report: 2022-12-31
LEI:
7478000063MY7I7H3N08 Financial statements
(HRK, as reported — unscaled; 94 line items across 2 annual periods)
| Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Revenue | HRK 687.1M | HRK 664.4M |
| Other income | HRK 15.3M | HRK 6.8M |
| Operating expenses | HRK 676.3M | HRK 661.3M |
| Employee benefits expense | HRK 84.9M | HRK 78.7M |
| Raw materials & consumables used | HRK 558.2M | HRK 517.6M |
| Depreciation & amortisation | HRK 17.9M | HRK 18.4M |
| Operating profit (EBIT) | HRK 26.1M | HRK 9.9M |
| Net finance income / (cost) | HRK 1.3M | -HRK 494.0K |
| Finance costs | HRK 1.0M | HRK 2.4M |
| Profit before tax | HRK 27.4M | HRK 9.4M |
| Income tax expense | HRK 5.1M | HRK 1.5M |
| Profit for the year | HRK 22.3M | HRK 7.9M |
| Total comprehensive income | HRK 22.3M | HRK 7.9M |
| Cash flow statement | ||
| Cash generated from operations | HRK 33.0M | HRK 58.3M |
| Net cash from operating activities | HRK 22.9M | HRK 55.0M |
| Net cash from investing activities | -HRK 26.1M | -HRK 29.7M |
| Purchase of PP&E (capex) | HRK 42.8M | HRK 32.2M |
| Purchase of intangibles | HRK 3.7M | HRK 185.0K |
| Net cash from financing activities | -HRK 29.0M | -HRK 51.6M |
| Proceeds from borrowings | HRK 11.6M | HRK 27.0M |
| Repayments of borrowings | HRK 37.8M | HRK 74.3M |
| Lease liability payments | HRK 2.7M | HRK 4.4M |
| Balance sheet | ||
| Total assets | HRK 622.8M | HRK 686.9M |
| Non-current assets | HRK 316.1M | HRK 272.6M |
| Property, plant & equipment | HRK 135.4M | HRK 112.3M |
| Current assets | HRK 306.7M | HRK 414.3M |
| Inventories | HRK 66.1M | HRK 81.8M |
| Trade & other receivables | HRK 196.3M | HRK 207.9M |
| Cash & equivalents | HRK 23.8M | HRK 56.1M |
| Total equity | HRK 445.1M | HRK 421.5M |
| Non-current liabilities | HRK 8.7M | HRK 25.1M |
| Long-term borrowings | HRK 6.3M | HRK 22.6M |
| Current liabilities | HRK 169.0M | HRK 240.4M |
| Deferred tax liabilities | HRK 121.0K | HRK 146.0K |
| Derived metrics | ||
| Free cash flow | -HRK 19.9M | HRK 22.8M |
| Operating margin | 3.8% | 1.5% |
| Net margin | 3.2% | 1.2% |
| Return on equity | 5.0% | 1.9% |
| Cash conversion ratio | 1.03× | 6.98× |
| Capex coverage | 0.54× | 1.71× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | HRK 14.2M | -HRK 29.5M |
| Adjustments For Decrease Increase In Trade Account Receivable | HRK 40.6M | -HRK 50.7M |
| Adjustments For Depreciation and Amortisation Expense | HRK 17.9M | HRK 18.4M |
| Adjustments For Gain Loss On Disposal of Investments In Subsidiaries Joint Ventures and Associates | HRK 389.0K | HRK 0 |
| Adjustments For Gains Losses On Fair Value Adjustment Investment Property | HRK 10.0K | HRK 0 |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Inventories | HRK 1.5M | HRK 224.0K |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade and Other Receivables | HRK 2.3M | HRK 1.8M |
| Adjustments For Increase Decrease In Trade and Other Payables | -HRK 66.1M | HRK 80.8M |
| Adjustments For Interest Expense | HRK 568.0K | HRK 2.3M |
| Adjustments For Interest Income | HRK 1.3M | HRK 1.5M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -HRK 10.9M | -HRK 1.8M |
| Adjustments For Provisions | -HRK 165.0K | -HRK 21.0K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | HRK 130.0K | -HRK 54.0K |
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | HRK 257.0K | HRK 653.0K |
| Cash Flows From Used In Operations Before Changes In Working Capital | HRK 44.3M | HRK 57.7M |
| Cash Receipts From Repayment of Advances and Loans Made To Other Parties Classified As Investing Activities | HRK 323.0K | HRK 519.0K |
| Changes In Inventories of Finished Goods and Work In Progress | -HRK 5.2M | HRK 1.3M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | HRK 27.8M | HRK 40.4M |
| Current Tax Liabilities Current | HRK 0 | HRK 6.3M |
| Deferred Tax Assets | HRK 2.7M | HRK 7.8M |
| Equity and Liabilities | HRK 622.8M | HRK 686.9M |
| Finance Income | HRK 2.3M | HRK 2.0M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | HRK 2.5M | HRK 2.0M |
| Income Taxes Paid Refund Classified As Operating Activities | HRK 9.4M | HRK 812.0K |
| Increase Decrease In Cash and Cash Equivalents | -HRK 32.3M | -HRK 26.4M |
| Increase Decrease Through Appropriation of Retained Earnings | HRK 0 | HRK 0 |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | HRK 1.3M | — |
| Increase Decrease Through Transactions With Owners | HRK 1.3M | HRK 0 |
| Intangible Assets Other Than Goodwill | HRK 3.7M | HRK 122.0K |
| Interest Paid Classified As Operating Activities | HRK 646.0K | HRK 2.5M |
| Interest Received Classified As Investing Activities | HRK 4.0K | HRK 34.0K |
| Investment Property | HRK 14.8M | HRK 8.7M |
| Investments In Subsidiaries | HRK 88.9M | HRK 92.1M |
| Issued Capital | HRK 244.2M | HRK 244.2M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | HRK 0 | HRK 51.1M |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | HRK 237.0K | HRK 216.0K |
| Noncurrent Loans and Receivables | HRK 47.7M | HRK 49.8M |
| Noncurrent Provisions | HRK 2.2M | HRK 2.4M |
| Noncurrent Trade Receivables | HRK 21.1M | HRK 0 |
| Other Cash Receipts From Sales of Equity Or Debt Instruments of Other Entities Classified As Investing Activities | HRK 7.1M | HRK 0 |
| Other Comprehensive Income | HRK 17.0K | HRK 3.0K |
| Other Comprehensive Income Net of Tax Gains Losses On Revaluation | HRK 21.0K | HRK 4.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -HRK 4.0K | -HRK 1.0K |
| Other Current Liabilities | HRK 27.1M | HRK 39.0M |
| Other Current Receivables | HRK 17.3M | HRK 17.3M |
| Other Expense By Nature | HRK 17.9M | HRK 43.3M |
| Other Reserves | HRK 166.7M | HRK 157.5M |
| Proceeds From Sales of Investment Property | HRK 301.0K | HRK 0 |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | HRK 12.8M | HRK 2.5M |
| Retained Earnings | HRK 22.4M | HRK 7.9M |
| Revenue and Operating Income | HRK 702.4M | HRK 671.2M |
| Statutory Reserve | HRK 12.4M | HRK 12.4M |
| Trade and Other Current Payables To Trade Suppliers | HRK 114.1M | HRK 154.6M |
| Treasury Shares | HRK 545.0K | HRK 545.0K |
Methodology
Every line item above is a fact tagged in Saponia kemijska, prehrambena i farmaceutska industrija d.d.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (HRK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.